Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. - Wikidata - wikimedia - TriplyDB

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

http://www.wikidata.org/entity/Q34430496

about

The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target Left atrial appendage closure devices Optimising stroke prevention in non-valvular atrial fibrillation Atrial fibrillation and stroke prevention A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.Preprocedural imaging for patients with atrial fibrillation and heart failure Minimally invasive surgical therapies for atrial fibrillation.Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.Atrial Fibrillation: The New Epidemic of the Ageing World Percutaneous Left Atrial Appendage Exclusion Therapy: Who, Why and How?Percutaneous elimination of the left atrial appendage in quest for effective and safe prevention of stroke in patients with atrial fibrillation.Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update.Stroke in atrial fibrillation--hope on the horizon?Present concepts in management of atrial fibrillation: From drug therapy to ablation.The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation Modern treatment of atrial fibrillation.Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?Antithrombotic medication for cardioembolic stroke prevention How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion Left atrial appendage exclusion for atrial fibrillation Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Non-pharmacological therapy for atrial fibrillation: managing the left atrial appendage Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation Drug therapy for atrial fibrillation: where do we go from here?Transcatheter occlusion of the left atrial appendage for stroke prevention.Left atrial appendage exclusion for stroke prevention in atrial fibrillation Intracardiac devices for stroke prevention.Percutaneous left atrial appendage closure in AF using Amplatzer Cardiac Plug: First single center experience from India The 5-year projection on the future of interventional cardiology.Optimization of Stroke Prophylaxis Strategies in Nonvalvular AF - Drugs, Devices or Both?Almanac 2011: Cardiac Arrhythmias and Pacing. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology.The role of antiplatelet therapy in the management of ischemic stroke: implementation of guidelines in current practice.Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.Complications From Left Atrial Appendage Exclusion Devices.Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both?Interventional treatment of structural heart disease.Percutaneous methods of left atrial appendage exclusion: an alternative to the internist.Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.Left atrial appendage exclusion: state-of-the-art.

P2860

Q26747263-7D89EF1D-3D27-4DBE-B2CF-28572794D5FB Q26799847-A4BCD58C-451C-4115-AC4F-E419B2CC5ED5 Q27001220-30F9EB76-6739-41D4-8A58-6B79C2770D15 Q28200609-BAABEB6C-D896-4BDB-A0EF-3800CECB73C5 Q28201536-CAEE9E8E-35AE-4282-ABCE-B3D41B615D8A Q30248612-BD17C1F8-50C0-4285-AAC1-476F0DF2F0C1 Q30448601-107057F7-DDA4-41A1-A828-27BBDC1E6EAE Q30466830-D0037EF3-C74E-4D8D-9F3A-6D4783DBB9C4 Q30484358-C4C383AF-06A8-484A-9767-AB0D948A038C Q33168630-D8C141D2-B072-485E-B390-32501CF4088F Q33585665-067095E4-D92F-4E11-BBD9-9C47FB66279B Q33941300-C2C1C5B1-2F33-426E-BE05-1086CC57393B Q34333253-4F4963FB-732D-4321-B681-9C34DF18AF53 Q34333317-5693883B-EE94-4391-9C49-74D30BB131DE Q34389483-476CF065-2C50-430D-9F57-9E834D4B6FF9 Q34772923-C684C130-0FAC-49D1-ABD4-DA1DAEAB90F7 Q34788250-7BA4745D-7743-4526-B8C2-072EE24BF5BF Q34931005-0A7ACB01-D02C-41E7-9FEC-769D9F04FD30 Q35142419-B4331D4F-3650-4B3B-8344-8DA7A02606C6 Q35214488-15EE7A7A-AEC5-4A47-9959-7BADDE8664FD Q35691402-954BA298-ABD9-4CE1-BA59-152329985BBF Q35752573-1B682B73-9984-460F-9F57-73CC8FE7A82F Q35990778-6284F1B4-CB48-4BB5-9AD3-34276F2D0A88 Q36087921-B02EB9E7-C6EF-456B-8EC6-BBDF5093D6C0 Q36303805-4F0855F6-94A8-42B9-90F4-F354C885B88F Q36314830-9F97AA91-F880-42D6-9C6D-E30B6D140E4F Q36344168-54D9B462-DBCE-413F-8C49-AD99178B6397 Q36366301-3ED3865D-29BA-4AD1-B81C-99F926BB44C6 Q36396667-1262A320-FE3D-4C94-AA34-9D992BAF0559 Q36559145-4626D2B1-3766-46A1-BC9E-E6FE622B01A3 Q36802853-10B385D5-1324-4C09-A113-20AE697FCB83 Q37066818-E894E11F-7317-4077-8059-F06055C90306 Q37204401-D64B26D8-7E8B-4EB4-BA7D-8EDC8C2AB554 Q37464600-8760B018-FC31-4D57-B09B-9CB39C439C4E Q37468869-FA9A26F5-49D7-4A74-B072-E59D241A63A8 Q37468892-DFA90EC7-19C2-4096-80DB-999E2236F502 Q37476932-E2272375-01D1-4041-931E-7D6EEF27215E Q37608298-0FB91EA2-C950-42E8-9127-B47EFA744225 Q37632397-35C3FDC7-021E-4306-9346-539DE94D69F7 Q37678317-729494FF-9879-4BBC-859E-2911D59D8196

P2860

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

http://www.wikidata.org/entity/Q34430496

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Percutaneous left atrial appen ...... lti-center feasibility trials.

@ast

Percutaneous left atrial appen ...... lti-center feasibility trials.

@en

type

label

Percutaneous left atrial appen ...... lti-center feasibility trials.

@ast

Percutaneous left atrial appen ...... lti-center feasibility trials.

@en

prefLabel

Percutaneous left atrial appen ...... lti-center feasibility trials.

@ast

Percutaneous left atrial appen ...... lti-center feasibility trials.

@en

P1433

Q34430496-0235D139-1B3B-40E8-B4B4-95E45E78CACB

P1476

Q34430496-C56CA91B-5CB1-4BE0-A568-85C63B53B75E

P2093

Q34430496-0805EF2E-06C8-468F-A634-AFE828E2BB07

Q34430496-1659C2F4-359A-42C7-9C6A-78AA5A5F54F8

Q34430496-20528699-7B17-4190-BB19-63FCCC75975A

Q34430496-5AAE8EEA-BFF6-4C18-88FE-5C948910CFF7

Q34430496-6353D9A3-18F5-4B2B-B1A1-5E97919B4AE2

Q34430496-69C81D61-6DDC-4AAD-A943-32B265C3824C

Q34430496-6A0DD6E9-75D9-40A2-9595-4B875905155F

Q34430496-7AFE26AA-C049-47E7-989B-51E656532A7D

Q34430496-89550829-0367-4BB5-A68E-AA36DA170105

Q34430496-90EA920F-37E7-443C-A166-8BFC90272C7D

P304

Q34430496-1B3857D2-C8A7-4DF0-B2D4-94D10E9874BB

P31

Q34430496-06898EDE-7FEF-4544-9CBC-4846A71EFD40

P356

Q34430496-13CB0F58-2323-4AF0-AE99-2FBA45A7CA2D

P407

Q34430496-F532A362-6FD8-4027-A9E8-6224B5860401

P433

Q34430496-33623D96-D6F5-44E9-9AC1-40526E48CA53

P478

Q34430496-32EDD018-D6E1-4EE7-AE78-9FD9C690CBA8

P50

Q34430496-169D2C7D-5585-489A-A52D-B0D3F861EF4C

Q34430496-39784694-47BE-41E8-BB44-B97ED6DFBAE6

P577

Q34430496-CC864FB2-C941-44DB-9D4B-32DC60D4E83F

P5875

Q34430496-247C7912-96DD-464E-849F-35F4F9791955

P698

Q34430496-8E62E118-92C6-4C43-BA68-94D8720DB0F3

P921

Q34430496-D3081EDD-64C2-4795-8CFA-5D9B02BFC9F8

P356

J.JACC.2005.03.042

P1433

Journal of the American College of Cardiology

P1476

Percutaneous left atrial appen ...... ulti-center feasibility trials

@en

P2093

Allan Skanes

http://www.w3.org/2001/XMLSchema#string

Antonio L Bartorelli

http://www.w3.org/2001/XMLSchema#string

Athena Poppas

http://www.w3.org/2001/XMLSchema#string

Bernhard Meier

http://www.w3.org/2001/XMLSchema#string

David O Williams

http://www.w3.org/2001/XMLSchema#string

Heyder Omran

http://www.w3.org/2001/XMLSchema#string

Horst Sievert

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Moses

http://www.w3.org/2001/XMLSchema#string

Kai Billinger

http://www.w3.org/2001/XMLSchema#string

Mark Reisman

http://www.w3.org/2001/XMLSchema#string

P304

9-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2005.03.042

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7750788

http://www.w3.org/2001/XMLSchema#string

P698

15992628

http://www.w3.org/2001/XMLSchema#string

P921